Ascendis Pharma A/S (ASND)
248.55
+9.27
(+3.87%)
USD |
NASDAQ |
Apr 13, 16:00
248.55
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Cash from Investing (TTM) : -9.612M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Novo Nordisk A/S | -12.02B |
| Evaxion AS | -- |
| DBV Technologies SA | -1.373M |
| Biodexa Pharmaceuticals Plc | -0.9012M |
| Trinity Biotech Plc | -8.178M |